6 Stocks Beating the Market

Apple, Alcoa among companies that have outperformed the S&P 500 over the past year

Author's Avatar
Dec 15, 2017
Article's Main Image

Agilent Technologies Inc. (A, Financial) has a market cap of $21.46 billion. It has outperformed the S&P 500 Index by 27.7% over the past 12 months.

Its shares are trading with a price-book (P/B) ratio of 4.45. According to the discounted cash flow (DCF) calculator, the stock is overpriced at $66.68 per share. The stock price is currently 47% above its 52-week low and 5.99% below its 52-week high.

The medical disagnostics and research company has a profitability and growth rating of 6 out of 10. Its return on equity (ROE) of 15.30% and return on assets (ROA) of 8.47% are outperforming 80% of other companies in the Global Diagnostics and Research industry. Financial strength has a rating of 7 out of 10. The cash-debt ratio of 1.33 is below the industry median of 3.13.

The company’s largest shareholder among the gurus is PRIMECAP Management (Trades, Portfolio) with 1.52% of outstanding shares, followed by the Vanguard Health Care Fund (Trades, Portfolio) with 0.46%, Jim Simons (Trades, Portfolio) with 0.17% and Columbia Wanger (Trades, Portfolio) with 0.09%.

With a market cap of $7.75 billion, Alcoa Corp. (AA, Financial) has outperformed the S&P 500 Index by 21.5% over the past 12 months.

Its shares are trading with a P/B ratio of 1.31. According to the DCF calculator, the stock is overpriced at $41.86 per share. The stock price is currently 49.45% above its 52-week low and 16.80% below its 52-week high.

The integrated aluminum company has a profitability and growth rating of 3 out of 10. Its ROE of 4.75% and ROA of 1.69% are outperforming 71% of other companies in the Global Aluminum industry. Financial strength has a rating of 6 out of 10 with a cash-debt ratio of 0.80.

Paul Singer (Trades, Portfolio) is the company's largest shareholder among the gurus with 4.5% of outstanding shares, followed by Steven Cohen (Trades, Portfolio) with 1.16% and First Pacific Advisors (Trades, Portfolio) with 1.13%.

Altaba Inc. (AABA, Financial) has a market cap of $62.22 billion. It has outperformed the S&P 500 Index by 51.6% over the past 12 months.

Its shares are trading with a P/B ratio of 1.91. The stock price is currently 86.30% above its 52-week low and 2.74% below its 52-week high.

The closed-end investment management company has a profitability and growth rating of 7 out of 10. Its ROE of -0.05% and ROA of -0.03% are underperforming 77% of other companies in the Global Asset Management industry. Financial strength has a rating of 6 out of 10 with a cash-debt ratio of 5.25.

The company’s largest shareholder among the gurus is First Pacific Advisors with 0.87% of outstanding shares, followed by Cohen with 0.7% and PRIMECAP Management with 0.67%.

With a market cap of $884.49 billion, Apple Inc. (AAPL, Financial) has outperformed the S&P 500 Index by 34% over the past 12 months.

Its shares are trading with a P/B ratio of 6.64. According to the DCF calculator, the stock is undervalued at $172.27 per share. The stock price is currently 50.11% above its 52-week low and 2.25% below its 52-week high.

The technology company has a profitability and growth rating of 7 out of 10. Its ROE of 36.56% and ROA of 14.16% are outperforming 94% of other companies in the Global Consumer Electronics industry. Financial strength has a rating of 6 out of 10. The cash-debt ratio of 0.64 is below the industry median of 1.44.

Warren Buffett (Trades, Portfolio) is the company's largest guru shareholder with 2.61% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) with 0.21%, Spiros Segalas (Trades, Portfolio) with 0.21% and Pioneer Investments (Trades, Portfolio) with 0.17%.

AbbVie Inc. (ABBV, Financial) has a market cap of $155.41 billion. It has outperformed the S&P 500 Index by 42.7% over the past 12 months.

Its shares are trading with a P/B ratio of 23.21. According to the DCF calculator, the stock is overpriced at $97.35 per share. The stock price is currently 64.25% above its 52-week low and 1.54% below its 52-week high.

The biopharmaceutical company has a profitability and growth rating of 7 out of 10. Its ROE of 114.74% and ROA of 9.95% are outperforming 75% of other companies in the Global Drug Manufacturers - Major industry. Financial strength has a rating of 5 out of 10. The cash-debt ratio of 0.25 is below the industry median of 2.89.

The company’s largest shareholder among the gurus is Larry Robbins (Trades, Portfolio) with 0.33% of outstanding shares, followed by Simons with 0.09%, Fisher with 0.04%, Joel Greenblatt (Trades, Portfolio) with 0.02% and Manning & Napier Advisors Inc. with 0.02%.

With a market cap of $101.37 billion, Ambev SA (ABEV, Financial) has outperformed the S&P 500 Index by 15.4% over the past 12 months.

Its shares are trading with a P/B ratio of 6.89. According to the DCF calculator, the stock is undervalued at $6.31 per share. The stock price is currently 33.40% above its 52-week low and 10.24% below its 52-week high.

The brewer has a profitability and growth rating of 7 out of 10. The ROE of 18.98% and ROA of 10.81% are outperforming 89% of other companies in the Global Beverages - Brewers industry. Financial strength has a rating of 7 out of 10. The cash-debt ratio of 2.51 is above the industry median of 0.60.

With 0.34% of outstanding shares,Ă‚ Manning & Napier Advisors is the company's largest guru shareholder, followed by Fisher with 0.16% and Howard Marks (Trades, Portfolio) with 0.03%.

Disclosure: I do not own any stocks mentioned in this article.